OTC · NICH
Nitches Inc.
$0.00+$0.00 (+12.5%)
Nitches Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.31% below the high.
Loading market information…
OTC · IVMED · USD
Stock price
Quote as of Sep 3, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
In Veritas Medical Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.77% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
In Veritas Medical Diagnostics, Inc. operates as a development-stage firm, dedicated to researching and developing medical devices designed for near-patient or point-of-care diagnostic applications. The company's flagship product is a prothrombin monitor, crucial for evaluating blood clotting in patients vulnerable to cardiovascular events and cerebrovascular accidents. Beyond this, In Veritas Medical Diagnostics is actively developing a suite of other innovative products. These include a consumer-oriented device to predict labor onset for maternity planning; a comprehensive biomarker monitor that measures key indicators for conditions such as heart attack, HIV, cholesterol levels, and cancer; a non-invasive, continuous blood glucose concentration measurement device; a digital scanning machine offering a non-invasive alternative to traditional 2D X-ray imaging; an osteoporosis detection and monitoring device providing instant bone mineral density readings for affected patients; and a portable digital strip reader for immunoassay applications. The company, incorporated in Inverness, United Kingdom, adopted its current name, In Veritas Medical Diagnostics, Inc., in 2005, evolving from its previous identity as In Vivo Medical Diagnostics, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+12.5%)
Nitches Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.31% below the high.
$0.00$0.00 (0.0%)
Safeplus International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.02$0.00 (0.0%)
Body Basics Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.93% below the high.
$0.00$0.00 (0.0%)
GIB Capital Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.89% below the high.
$0.00$0.00 (0.0%)
Puhui Wealth Investment Management Co., Ltd.: Financial Services · Asset Management.
$0.00$0.00 (0.0%)
NetMed, Inc.: Financial Services · Asset Management.
$0.00$0.00 (0.0%)
American Business Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
PMV Consumer Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
